Academic Content and Language Evaluation of This Article
CrossCheck and Google Search of This Article
Academic Rules and Norms of This Article
Citation of this article
Corresponding Author of This Article
Research Domain of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (9348)
All Articles published online
|
Publishing Process of This Article
|
Nov 15, 2016 (publication date) through Nov 23, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Diabetes
ISSN
1948-9358
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Michurina SV, Ishenko IJ, Klimontov VV, Archipov SA, Myakina NE, Cherepanova MA, Zavjalov EL, Koncevaya GV, Konenkov VI. Linagliptin alleviates fatty liver disease in diabetic db/db mice. World J Diabetes 2016; 7(19): 534-546 [PMID: 27895822 DOI: 10.4239/wjd.v7.i19.534] |
|---|---|
| URL: | https://www.wjgnet.com/1948-9358/full/v7/i19/534.htm |
| Number | Citing Articles |
| 1 |
Gea Ciccarelli, Gianfranco Di Giuseppe, Francesca Cinti, Simona Moffa, Teresa Mezza, Andrea Giaccari. Why do some glucose‐lowering agents improve non‐alcoholic fatty liver disease whereas others do not? A narrative review in search of a unifying hypothesis. Diabetes/Metabolism Research and Reviews 2023; 39(7) doi: 10.1002/dmrr.3668
|
| 2 |
Rita S. Patarrão, Nádia Duarte, Inês Coelho, Joey Ward, Rogério T. Ribeiro, Maria João Meneses, Rita Andrade, João Costa, Isabel Correia, José Manuel Boavida, Rui Duarte, Luís Gardete-Correia, José Luís Medina, Jill Pell, John Petrie, João F. Raposo, Maria Paula Macedo, Carlos Penha-Gonçalves. Prediabetes blunts DPP4 genetic control of postprandial glycaemia and insulin secretion. Diabetologia 2022; 65(5): 861 doi: 10.1007/s00125-021-05638-6
|
| 3 |
Christian Baumeier, Luisa Schlüter, Sophie Saussenthaler, Thomas Laeger, Maria Rödiger, Stella Amelie Alaze, Louise Fritsche, Hans-Ulrich Häring, Norbert Stefan, Andreas Fritsche, Robert Wolfgang Schwenk, Annette Schürmann. Elevated hepatic DPP4 activity promotes insulin resistance and non-alcoholic fatty liver disease. Molecular Metabolism 2017; 6(10): 1254 doi: 10.1016/j.molmet.2017.07.016
|
| 4 |
Christophe Regnault, Marie Usal, Sylvie Veyrenc, Karine Couturier, Cécile Batandier, Anne-Laure Bulteau, David Lejon, Alexandre Sapin, Bruno Combourieu, Maud Chetiveaux, Cédric Le May, Thomas Lafond, Muriel Raveton, Stéphane Reynaud.
Unexpected metabolic disorders induced by endocrine disruptors in
Xenopus tropicalis
provide new lead for understanding amphibian decline
. Proceedings of the National Academy of Sciences 2018; 115(19) doi: 10.1073/pnas.1721267115
|
| 5 |
S. V. Michurina, M. A. Cherepanova, I. Yu. Ishchenko, S. A. Arkhipov, V. V. Klimontov, E. L. Zav’yalov. Effect of Linagliptin on the Ratio of Apoptosis Regulators in the Model of Non-Alcoholic Fatty Liver Disease in db/db Mice. Bulletin of Experimental Biology and Medicine 2019; 167(2): 210 doi: 10.1007/s10517-019-04493-1
|
| 6 |
Yan Li, Julei Zhang, Qin Zhou, Hongtao Wang, Songtao Xie, Xuekang Yang, Peng Ji, Wanfu Zhang, Ting He, Yang Liu, Kejia Wang, Xiaoqiang Li, Jihong Shi, Dahai Hu. Linagliptin inhibits high glucose‐induced transdifferentiation of hypertrophic scar‐derived fibroblasts to myofibroblasts via IGF/Akt/mTOR signalling pathway. Experimental Dermatology 2019; 28(1): 19 doi: 10.1111/exd.13800
|
| 7 |
Snehasish Nag, Samanwita Mandal, Oindrila Mukherjee, Tanmay Majumdar, Satinath Mukhopadhyay, Rakesh Kundu. Vildagliptin inhibits high fat and fetuin-A mediated DPP-4 expression, intracellular lipid accumulation and improves insulin secretory defects in pancreatic beta cells. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2024; 1870(3): 167047 doi: 10.1016/j.bbadis.2024.167047
|
| 8 |
Sven Wolfgang Görgens, Kerstin Jahn-Hofmann, Dinesh Bangari, Sheila Cummings, Christiane Metz-Weidmann, Uwe Schwahn, Paulus Wohlfart, Matthias Schäfer, Maximilian Bielohuby, Marcia B. Aguila. A siRNA mediated hepatic dpp4 knockdown affects lipid, but not glucose metabolism in diabetic mice. PLOS ONE 2019; 14(12): e0225835 doi: 10.1371/journal.pone.0225835
|
| 9 |
Jenni Virta, Sanna Hellberg, Heidi Liljenbäck, Mia Ståhle, Johanna M.U. Silvola, Jenni Huusko, Mirva Söderström, Juhani Knuuti, Pirjo Nuutila, Seppo Ylä-Herttuala, Maria F. Gomez, Anne Roivainen, Antti Saraste. Effects of dipeptidyl peptidase 4 inhibition on inflammation in atherosclerosis: A 18F-fluorodeoxyglucose study of a mouse model of atherosclerosis and type 2 diabetes. Atherosclerosis 2020; 305: 64 doi: 10.1016/j.atherosclerosis.2020.03.029
|
| 10 |
S. V. Michurina, I. Yu. Ishchenko, S. A. Arkhipov, M. A. Cherepanova, D. V. Vasendin, E. L. Zavjalov. Apoptosis in the liver of male <em>db/db</em> mice during the development of obesity and type 2 diabetes. Vavilov Journal of Genetics and Breeding 2020; 24(4): 435 doi: 10.18699/VJ20.43-o
|
| 11 |
A. I. Korbut, V. V. Klimontov, N. B. Orlov, A. S. Khotskina, E. L. Zav’yalov. Relationships between Body Composition and Plasma Levels of Pancreatic, Gut, and Adipose Tissue Hormones in db/db Mice, a Model of Type 2 Diabetes Mellitus. Bulletin of Experimental Biology and Medicine 2019; 167(3): 325 doi: 10.1007/s10517-019-04519-8
|
| 12 |
Svetlana Viktorovna Michurina, Natalia Nikolaevna Svechnikova, Andrey Yurievich Letyagin, Irina Yurievna Ishchenko, Sergey Alekseevich Arkhipov, Anastasia Olegovna Solovyova. Digital 3D technology in the assessment of LYVE-1 expression in skin eczema and type 2 diabetes mellitus. 2021 IEEE Ural-Siberian Conference on Computational Technologies in Cognitive Science, Genomics and Biomedicine (CSGB) 2021; : 250 doi: 10.1109/CSGB53040.2021.9496033
|
| 13 |
Yasuji Komorizono, Kaori Hosoyamada, Naoko Imamura, Shoko Kajiya, Yasuhiro Hashiguchi, Norio Ueyama, Hirohiko Shinmaki, Nobuyuki Koriyama, Masako Tsukasa, Tetsuro Kamada. Metformin dose increase versus added linagliptin in non‐alcoholic fatty liver disease and type 2 diabetes: An analysis of the J‐LINK study. Diabetes, Obesity and Metabolism 2021; 23(3): 832 doi: 10.1111/dom.14263
|
| 14 |
Manuel Soto-Catalán, Lucas Opazo-Ríos, Hernán Quiceno, Iolanda Lázaro, Juan Antonio Moreno, Carmen Gómez-Guerrero, Jesús Egido, Sebastian Mas-Fontao. Semaglutide Improves Liver Steatosis and De Novo Lipogenesis Markers in Obese and Type-2-Diabetic Mice with Metabolic-Dysfunction-Associated Steatotic Liver Disease. International Journal of Molecular Sciences 2024; 25(5): 2961 doi: 10.3390/ijms25052961
|
| 15 |
Heng Li, Junjun Zhang, Li Lin, Lishuai Xu. Vascular protection of DPP-4 inhibitors in retinal endothelial cells in in vitro culture. International Immunopharmacology 2019; 66: 162 doi: 10.1016/j.intimp.2018.10.040
|
| 16 |
S. V. Michurina, I. Yu. Ishchenko, M. A. Cherepanova, S. A. Arkhipov, Yu. I. Borodin, E.L. Zavjalov, D.V. Vasendin. Apoptosis in the liver of db/db Mice Female in Postnatal Ontogenesis. 2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\Systems Biology (BGRS\SB) 2018; : 5 doi: 10.1109/CSGB.2018.8544866
|
| 17 |
Anton Korbut, Vadim. Klimontov, Iuliia Taskaeva, Nataliya Bgatova, Evgenij Zavyalov. Empagliflozin and linagliptin ameliorate podocyte injury and enhance autophagy in a model of type 2 diabetic nephropathy. 2018 11th International Multiconference Bioinformatics of Genome Regulation and Structure\Systems Biology (BGRS\SB) 2018; : 28 doi: 10.1109/CSGB.2018.8544785
|
| 18 |
Golnaz Ranjbar, Dimitri P. Mikhailidis, Amirhossein Sahebkar. Effects of newer antidiabetic drugs on nonalcoholic fatty liver and steatohepatitis: Think out of the box!. Metabolism 2019; 101: 154001 doi: 10.1016/j.metabol.2019.154001
|
| 19 |
Xiaosong Yang, Pengjie Zhang, Feixue Zhang, Zhiqiang Ke, Qingjie Chen, Chao Liu. Protective effect of hypoglycemic granule against diabetes‐induced liver injury by alleviating glycolipid metabolic disorder and oxidative stress. Journal of Cellular Biochemistry 2020; 121(5-6): 3221 doi: 10.1002/jcb.29588
|
| 20 |
F.O. Santos, B.R.O. Correia, T.S. Marinho, Sandra Barbosa-da-Silva, Carlos A. Mandarim-de-Lacerda, Vanessa Souza-Mello. Anti-steatotic linagliptin pleiotropic effects encompasses suppression of de novo lipogenesis and ER stress in high-fat-fed mice. Molecular and Cellular Endocrinology 2020; 509: 110804 doi: 10.1016/j.mce.2020.110804
|
| 21 |
Ryotaro Bouchi, Tatsuya Fukuda, Takato Takeuchi, Yujiro Nakano, Masanori Murakami, Isao Minami, Hajime Izumiyama, Koshi Hashimoto, Takanobu Yoshimoto, Yoshihiro Ogawa. Dipeptidyl peptidase 4 inhibitors attenuates the decline of skeletal muscle mass in patients with type 2 diabetes. Diabetes/Metabolism Research and Reviews 2018; 34(2) doi: 10.1002/dmrr.2957
|
| 22 |
Junkichi Kanda, Megumi Furukawa, Nobuo Izumo, Taketoshi Shimakura, Noriaki Yamamoto, Hideaki E. Takahashi, Hiroyuki Wakabayashi. Effects of the linagliptin, dipeptidyl peptidase-4 inhibitor, on bone fragility induced by type 2 diabetes mellitus in obese mice. Drug Discoveries & Therapeutics 2020; 14(5): 218 doi: 10.5582/ddt.2020.03073
|